Related Experiment Video
Updated: Apr 4, 2026

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
Transcatheter Aortic and Mitral Valve Implantation (TAMVI) in Native Rheumatic Valves
Adanna C Akujuo1, Sophia L Dellis1, Lewis W Britton1
1Division of Cardiothoracic Surgery, Albany Medical Center, Albany, New York.
Abstract:
A 68-year-old female with moderate to severe aortic stenosis and severe mitral stenosis, deemed too high risk for surgery (STS mortality risk = 12.3%) with a porcelain aorta, was successfully treated with a transcatheter aortic and mitral valve implantation (TAMVI) via a transapical approach. A 23 mm Sapien valve (Edwards Lifesciences, Irvine, CA, USA) was placed in the aortic position and a 29 mm inverted Sapien valve (Edwards Lifesciences) in the mitral position.
Related Concept Videos
Mitral Stenosis III: Medical Management
Rheumatic Heart Disease III: Medical Management
Mitral Regurgitation III: Medical Management
Mitral Stenosis I: Introduction
Mitral Stenosis IV: Nursing Management
Mitral Valve Prolapse II: Assessment and Management

